Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration

被引：0
|
作者：
Monica Dalal
Naima Jacobs-El
Benjamin Nicholson
Jingsheng Tuo
Emily Chew
Chi-Chao Chan
Robert Nussenblatt
Frederick Ferris
Catherine Meyerle
机构：
[1] National Eye Institute,Laboratory of Immunology
[2] National Institutes of Health,Division of Epidemiology and Clinical Applications
[3] National Eye Institute,undefined
[4] National Institutes of Health,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2013年 / 251卷
关键词：
Akt/mTOR; Choroidal neovascularization; Neovascular age-related macular degeneration; Palomid 529;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2705 / 2709
页数：4
相关论文
共 50 条
  • [1] Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration
    Dalal, Monica
    Jacobs-El, Naima
    Nicholson, Benjamin
    Tuo, Jingsheng
    Chew, Emily
    Chan, Chi-Chao
    Nussenblatt, Robert
    Ferris, Frederick
    Meyerle, Catherine
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (12) : 2705 - 2709
  • [2] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [3] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [4] VEGF inhibitors for the treatment of neovascular age-related macular degeneration
    Barakat, Mark Rami
    Kaiser, P. K.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (05) : 637 - 646
  • [5] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [6] Current advances in the treatment of neovascular age-related macular degeneration
    Villegas, Victor M.
    Aranguren, Luis A.
    Kovach, Jaclyn L.
    Schwartz, Stephen G.
    Flynn, Harry W., Jr.
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (02) : 273 - 282
  • [7] Review of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    Stewart, Michael W.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 81 - 93
  • [8] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [9] Pegaptanib Sodium in the Treatment of Neovascular Age-Related Macular Degeneration
    Querques, Giuseppe
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 225 - 234
  • [10] Treatment of neovascular age-related macular degeneration in patients with diabetes
    Cummings, Michael
    Cunha-Vaz, Jose
    CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 369 - 375
12345